Evidence-Based Performance and Quality Improvement in the Acute Cardiac Care Setting

Critical Care Clinics

Volumn 24, Issue 1, 2008, Pages 201-229

  Riba, Arthur L ^a  

^a Cardiac Care Units   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; METOPROLOL SUCCINATE; NITRIC ACID DERIVATIVE; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AORTA DISSECTION; BLEEDING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CONTINUING EDUCATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOCARDITIS; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RUPTURE; HEART TAMPONADE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTENSION; HYPOTENSION; HYPOVOLEMIA; LUNG EMBOLISM; MEDICAID; MEDICAL EDUCATION; MITRAL VALVE REGURGITATION; OBESITY; PATIENT CARE; PNEUMOTHORAX; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; REVIEW; SMOKING CESSATION PROGRAM; SUDDEN DEATH;

AMERICAN HEART ASSOCIATION; CORONARY CARE UNITS; CORONARY DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; REGISTRIES; UNITED STATES;

EID: 38849159246     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2007.09.002     Document Type: Review

References (149)

1. Lynn J., Baily M.A., Bottrell M., et al. The ethics of using quality improvement methods in health care. Ann Intern Med 146 (2007) 666-673
2. Ford E.S., Ajani U.A., Croft J.B., et al. Explaining the decrease in US deaths for coronary disease, 1980-2000. N Engl J Med 356 (2007) 2388-2398
3. Available at: www.acc.org; www.americanheart.org.
4. Smith S.C., Allen J., Blair S.N., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update. J Am Coll Cardiol 47 (2006) 2130-2139
5. Berwick D.M. Developing and testing changes in delivery of care. Ann Intern Med 128 (1998) 651-656
6. Centers for Medicare and Medicaid Services Hospital Quality Initiative (HQI). Available at: http://www.cms.hhs.gov/HospitalQualityInits/.
7. Williams S.C., Schmaltz S.P., Morton D.J., et al. Quality of care in US hospitals as reflected by standardized measures, 2002-2004. N Engl J Med 353 (2005) 255-264
8. United States Department of Health and Human Services. Available at: www.hospitalcompare.hhs.gov.
9. Petersen L.A., Woodard L.D., Urech T., et al. Does pay for performance improve the quality of health care?. Ann Intern Med 145 (2006) 265-272
10. Lindenauer P.K., Remus D., Roman S., et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med 356 (2007) 486-496
11. Glickman S.W., Ou F.S., DeLong E.R., et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA 297 (2007) 2373-2380
12. National Quality Forum. Available at: http://www.qualityforum.org.
13. Premier Inc. Centers for Medicare and Medicaid Services (CMS)/Premier Hospital Quality Incentive Demonstration Project: project overview and findings from year one. Available at: http://www.premierinc.com.
14. CMS/Premier Hospital Quality Incentive Demonstration (QHID). Improvements continue in year 2. Available at: http://www.premierinc.com.
15. Berthiaume J.T., Tyler P.A., Ng-Osorio J., et al. Aligning financial incentives with "Get With The Guidelines" to improve cardiovascular care. Am J Manag Care 10 (2004) 501-504
16. Malenka J.D., and O'Connor G.T. The Northern New England Cardiovascular Disease Study Group: a regional collaborative effort for CQI in cardiovascular disease. Jt Comm J Qual Improv 24 (1998) 594-600
17. Ellerbeck E.F., Jencks S.F., Radford J.M., et al. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA 273 (1995) 1509-1514
18. Marciniak T.A., Ellerbeck E.F., Radford J.M., et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA 279 (1998) 1351-1357
19. Ellerbeck E.F., Kresowik T.F., Hemann R.A., et al. Impact of quality improvement activities on care for acute myocardial infarction. Int J Qual Health Care 12 (2000) 305-310
20. Fonarow G.C., and Gawlinski A. Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles. Am J Cardiol 85 (2000) 10A-17A
21. Fonarow G.C., Gawlinski A., Moughrabi S., et al. Improved treatment of coronary heart disease by implementation of a cardiac hospitalization atherosclerosis management program (CHAMP). Am J Cardiol 87 (2001) 819-822
22. Mehta R.H., Montoye C.K., Gallogy M., et al. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) initiative. JAMA 287 (2002) 1269-1276
23. LaBresh K.A., Ellrodt A.G., Gliklich R., et al. Get with the guidelines for cardiovascular secondary prevention. Arch Intern Med 164 (2004) 203-209
24. Scott I.A., Denaro C.P., Hickey A.C., et al. Optimising care of acute coronary syndromes in three Australian hospitals. Int J Qual Health Care 16 (2004) 275-284
25. Scott I.A., Denaro C.P., Bennett C.J., et al. Achieving better in-hospital and after-hospital care of patients with acute cardiac disease. Med J Aust 180 (2004) S83-S88
26. Fonarow G.C., Abraham W.T., Albert N.M., et al. Influence of a performance improvement initiative on quality of care for patients hospitalized with heart failure. Results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Arch Intern Med 167 14 (2007) 1493-1502
27. Koelling T.M., Montoye C.K., Fang J., et al. Heart failure quality improvement intervention reduces 30-day risk of death and readmission: the mid-Michigan guidelines applied in practice heart failure initiative. Circulation 112 II (2005) 641
28. Montoye C.K., and Eagle K.A. An organizational framework for the AMI ACC-GAP project. J Am Coll Cardiol 46 (2005) 2B-29B
29. Spertus J.A., Eagle K.A., Krumholz H.M., et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Circulation 111 (2005) 1703-1712
30. Mehta R.H., Peterson E.D., and Califf R.M. Performance measures have a major effect on cardiovascular outcomes: a review. Am J Med 120 (2007) 398-402
31. Werner R.M., and Bradlow E.T. Relationship between Medicare's hospital compare performance measures and mortality rates. JAMA 296 (2006) 2694-2702
32. Bradley E.H., Herrin J., Elbel B., et al. Hospital quality for acute myocardial infarction. JAMA 296 (2006) 72-78
33. Granger C.B., Steg P.G., Peterson E., et al. Medication performance measures and mortality following acute coronary syndromes. Am J Med 118 (2005) 858-865
34. Eagle K.A., Montoye C.K., Riba A.L., et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction. J Am Coll Cardiol 46 (2005) 1242-1248
35. Peterson E.D., Roe M.T., Mulgund J., et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 295 (2006) 1912-1920
36. Fox K.A.A., Steg P.G., Eagle K.A., et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 297 (2007) 1892-1900
37. Available at: www.NRMI.org.
38. CRUSADE National Quality Improvement Website. Available at: http://www.crusadeQI.com.
39. Available at: http://www.outcomes-umassmed.org/GRACE/bibliography.cfm.
40. Steg P.G., Goldberg R.J., Gore J.M., et al. GRACE Investigators. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 90 (2002) 358-363
41. Scott I.A., Coory M.D., and Harper C.M. The effects of quality improvement interventions on in-hospital mortality after acute myocardial infarction. Med J Aust 175 (2001) 465-470
42. Soumerai S.B., McLaughlin T.J., Gurwitz J.H., et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA 279 (1998) 1358-1363
43. Bradley E.H., Holmboe E.S., Mattera J.A., et al. A qualitative study of increasing B-blocker use after myocardial infarction. Why do some hospitals succeed?. JAMA 285 (2001) 2604-2611
44. Bailey T.C., Noirot L.A., Blickensderfer A., et al. An intervention to improve secondary prevention of coronary heart disease. Arch Intern Med 167 (2007) 586-590
45. Butler J., Speroff T., Arbogast P.G., et al. Improved compliance with quality measures at hospital discharge with a computerized physician order entry system. Am Heart J 151 (2006) 643-653
46. Goff Jr. D.C., GU L., Cantley L.K., et al. Quality of care for secondary prevention for patients with coronary heart disease. Results of the Hastening the Effective Application of Research through Technology (HEART) trial. Am Heart J 146 (2003) 1045-1051
47. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. J Am Med Assoc 282 (1999) 1458-1465
48. Leapfrog Group. The Leapfrog Group Hospital Patient Safety Survey, April 2003-March 2004 (2004), Leapfrog Group, Washington, DC
49. US News & World Report. America's best hospitals. Available at: http://www.usnews.com/besthospitals.
50. Health Grades Website. Available at: http://www.healthgrades.com.
51. New York State and other states' initiatives of public reporting of physicians performance. The external review of hospital quality: state initiatives. Office of the Inspector General, DHHS. Department of Health and Human Services Web page. Available at: http://www.oig.hhs.gov/oei/reports/oei-01-97-00054.pdf.
52. Epstein A.M., Lee T.H., and Hamel M.B. Paying physicians for high-quality care. N Engl J Med 350 (2004) 406-410
53. Centers for Medicare & Medicaid. Premier hospital-quality incentive demonstration. Available at: http://www.cms.hhs.gov/hospitalqualityinits/35_hospitalpremier.asp#topof page.
54. Available at: www.bcbsm.com.
55. US Government Accountability Office. Hospital quality data: CMS needs more rigorous methods to ensure reliability of publicly released data (2006), US Government Accountability Office, Washington, DC Publication GAO-06-54
56. American Hospital Association. Hospital quality alliance. Available at: http://www.aha.org/aha/key_issues/qualityalliance/.
57. Available at: http://www.ama-assn.org/go/physicianconsortium.
58. Joint Commission for Accreditation of Healthcare Organizations. Performance measures. Available at: +http://www.jcaho.org/pms/core+measures/cr_hos_cm.htm.
59. Quality improvement organizations: statement of work. Available at: http://cms.hhs.gov/qio/2.asp.
60. Fonarow G.C., and Ballantyne C.M. In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now. Circulation 103 (2001) 2768-2770
61. Muhlstein J.B., Horne B.O., Glair T.L., et al. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol 87 (2001) 257-261
62. Butler J., Arbogast P.G., Belue R., et al. Outpatient adherence to beta blocker therapy after acute myocardial infarction. J Am Coll Cardiol 40 (2002) 1589-1595
63. Butler J., Arbogast P.G., Daugherty J., et al. Outpatient utilization of angiotensin converting enzyme inhibitors among heart failure patients after hospital discharge. J Card Fail 9 (2003) S77
64. Fonarow G.C., Gheorghiade M., and Abraham W.T. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review. Am J Cardiol 94 (2004) 1155-1160
65. Krumholz H.M., Radford J.M., Wang Y., et al. National use and effectiveness of beta blockers for the treatment of elderly patients after acute myocardial infarction: national cooperative cardiovascular project. JAMA 280 (1998) 623-629
66. Rogers W.J., Canto J.G., Lambrew C.T., et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 36 (2000) 2056-2063
67. Stafford R.S., and Radley D.C. The underutilization of cardiac medications of proven benefit, 1990-2002. J Am Coll Cardiol 41 (2003) 56-61
68. Ellis J., Erickson S., Stevenson J., et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med 19 (2004) 638-645
69. Mehta R.H., Roe M.T., Chen A.Y., et al. Changing practice for non-ST elevation acute coronary syndromes: trends from the CRUSADE Quality Improvement (QI) Initiative from 2002-2004. Circulation 112 II (2005) 793-794
70. McLaughlin T.J., Soumerai S.B., Willson D.J., et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 156 (1996) 799-805
71. Krumholz H.M., Anderson J.L., Brooks N.H., et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction. A report of the ACC/AHA Task Force on Performance Measures (writing committee to develop performance measures on ST-E and Non-STE MI). J Am Coll Cardiol 47 (2006) 236-265
72. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 50 (2007) 652-726
73. The Clopidogrel in Unstable Angina to Prevent Events trial investigators. Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 348 (2001) 494-502
74. Mehta S., Yusuf S., Peters R.J.G., et al. Effects of pretreatment with Clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527
75. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of Clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 355 (2005) 1607-1621
76. Sabatine M.S., Cannon C.P., Gibson C.M., et al. Addition of Clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
77. The PURSUIT trial investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339 (1998) 436-443
78. Kastrati A., Mehilli J., Neumann F.J., et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after Clopidogrel pretreatment. The ISAR-RACT 2 randomized trial. JAMA 295 (2006) 1531-1538
79. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887
80. Stone G.W., McLaurin B.T., Cox D.A., et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355 (2006) 2203-2216
81. OASIS 5- The fifth organization to assess strategies in acute ischemic syndromes investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 354 (2005) 1464-1476
82. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid-lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
83. Bonow R.O., Bennett S., Casey D.E., et al. ACC/AHA clinical performance measures for adults with chronic heart failure. A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (writing committee to develop heart failure clinical performance measures). J Am Coll Cardiol 46 (2005) 1144-1178
84. Krumholz H.M., Amatruda J., Smith G.L., et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 39 (2002) 83-89
85. Phillips C.O., Wright S.M., Kern D.E., et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure. JAMA 291 (2004) 1358-1367
86. Jafri S., Riba A.L., Montoye C., et al. Improving compliance with heart failure core measures-Michigan Heart Failure Discharge Document Initiative. J Am Coll Cardiol 47 (2006) 260A
87. Pfeffer M.A., McMurray J.J., Velazquez E.F., et al. Valsartan, Captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
88. Pfeffer M.A., Swedberg K., Granger C.B., et al., for the CHARM investigators and committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362 (2003) 759-766
89. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
90. The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
91. McAlister F.A., Ezekowitz J., Hooton N., et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction. A systematic review. JAMA 297 (2007) 2502-2514
92. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
93. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2057
94. Pitt B., Zannad F., Remme W.J., et al., for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717
95. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
96. Bozkurt B., Agoston I., and Knowlton A.A. Complications of inappropriate use of Spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol 41 (2003) 211-214
97. Packer M., Bristow M.R., Cohn J.N., et al. The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
98. Packer M., Coats A.J., Fowler M.B., et al., for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of Carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
99. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial. Lancet 353 (1999) 9-13
100. MERIT-HF Study Group. Effect of metprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353 (1999) 2001-2007
101. Packer M., Fowler M.B., Roecker E.B., et al., for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of Carvedilol on the morbidity of patients with severe chronic heart failure: results of the the Carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106 (2002) 2194-2199
102. Dargie H.J. Effect of Carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet 357 (2001) 1385-1390
103. Yusuf S., Pfeffer M.A., Swedberg K., et al., for the CHARM investigators and committees. Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-Preserved trial. Lancet 362 (2003) 771-781
104. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 48 (2006) 1064-1108
105. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation-executive summary. A report of the American College of Cardiology/American Heart Association Task Fore on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 48 (2006) 854-906
106. The ESCAPE investigators, and ESCAPE Coordinators Evaluation Study of congestive heart failure and pulmonary artery catheterization effectiveness. JAMA 294 (2005) 1625-1633
107. Shah M.R., Hasselbled V., Stevenson L.W., et al. Impact of the pulmonary artery catheter in critically ill patients. JAMA 294 (2005) 1664-1670
108. Gore J.M., Goldberg R.J., Spodick D.H., et al. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial: a prospective autopsy study. Chest 88 (1985) 567-572
109. Zion M.M., Balkin J., Rosenmann D., et al. Use of pulmonary artery catheters in patients with acute myocardial infarction. Chest 98 (1990) 1331-1335
110. Connors Jr. A.F., Speroff T., Dawson N.V., et al., for the SUPPORT investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276 (1996) 889-897
111. Malenka D.J., and O'Connor G.T. A regional collaborative effort for CQI in cardiovascular disease. Northern New England Cardiovascular Study Group. Jt Comm J Qual Improv 21 11 (1995) 627-633
112. Available at: http://www.nnecdsg.org/ pub_lit_2.htm.
113. Wang O.J., Want Y., Lichtman J.H., et al. "America's Best Hospitals" in the treatment of acute myocardial infarction. Arch Intern Med 167 13 (2007) 1345-1351
114. Liu J.H., Zingmond D.S., McGory M.L., et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 296 (2006) 1973-1980
115. Khadour F.H., Fu Y., Chang W.C., et al. Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes. Can J Cardiol 19 3 (2003) 257-263
116. Labarere J., Belle L., Fourny M., et al. Outcomes of myocardial infarction in hospitals with percutaneous coronary intervention facilities. Arch Intern Med 167 (2007) 913-920
117. Sheifer S.E., Escarce J.J., and Schulman K.A. Race and sex differences in the management of coronary artery disease. Am Heart J 139 (2000) 848-857
118. Peterson E.D., Shaw L.K., DeLong E.R., et al. Racial variation in the use of coronary revascularization procedures: are the differences real? Do they matter. N Engl J Med 336 (1997) 480-486
119. Ford E., Newman J., and Deosaransingh K. Racial and ethnic differences in the use of cardiovascular procedures: findings from the California Cooperative Cardiovascular Project. Am J Public Health 90 (2000) 1128-1134
120. Sonel A.F., Good C.B., Mulgund J., et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early implementation of the Acc/AHA guidelines?). Circulation 111 (2006) 1225-1232
121. Sabatine M.S., Blake G.J., Drazner M.H., et al. Influence of race on death and ischemic complications in patients with non-ST elevation acute coronary syndromes despite modern, protocol-guided treatment. Circulation 111 (2006) 1217-1224
122. Popescu I., Vaughan-Sarrazin M., and Rosenthal G.E. Differences in mortality and use of revascularization in black and white patients with acute MI admitted to hospitals with and without revascularization services. JAMA 297 (2007) 2489-2495
123. Wang T.Y., Chen A.Y., Roe M.T., et al. Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative. Am J Cardiol 100 (2007) 391-396
124. Stone P.H., Thompson B., Anderson H.V., et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III registry. JAMA 275 (1996) 1104-1112
125. Vaccarino V., Rathore S.S., Wenger N.K., et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 3353 (2005) 671-682
126. Menon V., Rumsfeld J.S., Roe M.T., et al. Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes. Am J Med 119 (2006) 584-590
127. Mehta R.H., Das S., Tsai T.T., et al. Quality improvement initiative and its impact on the management of patients with acute myocardial infarction. Arch Intern Med 160 (2000) 3057-3062
128. Eagle K.A., Gallogly M., Mehta R.H., et al. Taking the national guideline for care of acute myocardial infarction to the bedside: development of the Guideline Applied to Practice (GAP) initiative in southeast Michigan. Jt Comm J Qual Improv 28 (2002) 1-19
129. Montoye C.K., Mehta R.H., Baker P.L., et al., on behalf of the GAP steering committee and investigators. A rapid-cycle collaborative model to promote guidelines for acute myocardial infarction. J Comm J Quality Safety 29 (2003) 468-478
130. Mehta R.H., Montoye C.K., Faul J., et al. Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use: American College of Cardiology AMI GAP project in Michigan: Flint and Saginaw expansion. J Am Coll Cardiol 43 (2004) 2166-2173
131. Riba AL, Montoye CK, Mehta, RH, et al, on behalf of the ACC GAP Steering Committee. The American College of Cardiology (ACC) Acute Myocardial Infarction (AMI) Guidelines Applied in Practice (GAP) southeastern Michigan expansion project: a collaborative quality improvement (QI) model. Presented at the European Society of Cardiology Conference. Berlin, Germany, September 2003.
132. Eagle K.A., Mehta R.H., Riba A.L., et al. Taking the ACC/AHA guidelines for care of acute myocardial infarction to the bedside: the GAP projects in southeast Michigan. Am Heart J 148 (2004) S49-S61
133. Institute for Healthcare Improvement breakthrough series. Available at: www.IMI.org.
134. Lappe J.M., Muhlstein J.B., Lappe D.L., et al. Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med 141 (2004) 446-453
135. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
136. Cannon C.P., Gibson C.M., and Lambrew C.T. Relationship of symptom onset to balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
137. De Luca G., Suryapranata H., Ottervanger J.P., et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225
138. McNamara R.L., Wang Y., Herrin J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 47 (2006) 2180-2186
139. Bradley E.H., Herrin J., Wang Y., et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 355 (2006) 2308-2320
140. Available at: www.d2balliance.org; or https://d2b.acc.org.
141. Fonarow G.C., and for the ADHERE scientific advisory committee. The Acute Decompensated heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 Suppl 7 (2003) S21-S30. http://www.adhereregistry.com/publications/manuscripts/adhere_in_ricm.pd f Available at:
142. Fonarow G.C., Abraham W.T., Albert N.M., et al. Organized program to initiative life-saving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J 148 1 (2004) 43-51
143. Gheorghiade M., Abraham W.T., Albert N.M., et al., OPTIMIZE-HF investigators and coordinators. Systolic blood pressure at admission, clinical characteristics and outcomes in patients hospitalized with acute heart failure. JAMA 296 18 (2006) 2217-2226
144. Joint Commission on Accreditation of Healthcare Organization. Available at: www.JCAHO.com.
145. Scott I.A., Darwin I.C., Harvey K.H., et al. Multisite, quality-improvement collaboration to optimize cardiac care in Queensland public hospitals. Med J Aust 180 (2004) 392-397
146. Pearson T.A., Horne B.D., Maycock C.A., et al. An institutional heart failure discharge medication program reduces future cardiovascular readmissions and mortality: an analysis of 19,083 heart failure patients. Circulation 104 (2001) (suppl II):II-838
147. Rollow A., Lied T.R., McGann P., et al. Assessment of the Medicare Quality Improvement Organization Program. Ann Intern Med 145 (2006) 342-353
148. Available at: http://www.cms.hhs.gov/demoprojectsevalrpts.
149. Chen J., Rathore S.S., Radford M.J., et al. JCAHO accreditation and quality of care for acute myocardial infarction. Health Aff 22 (2003) 243-254